Crh Plc

CRH gets 74% of its 2025 net income from the U.S., even though it operates 3,960 locations across 29 countries.

If you own CRH, you own a U.S. construction story wearing an Irish passport.

crh

industrials large cap updated mar 13, 2026
$117.72
market cap ~$79B · 52-week range $77–$132
xvary composite: 56 / 100 · below average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
CRH sells the stone, cement, concrete, asphalt, and road work that show up before your highway project gets delayed.
how it gets paid
Last year Crh made $37.4B in revenue. Americas Materials was the main engine at $16.8B, or 45% of sales.
why it's growing
Revenue grew 5.3% last year. Latest-quarter revenue was $28.0B, up 153% vs. prior year, while EPS reached $3.99, up 81%.
what just happened
CRH posted a clean beat, with quarterly EPS of $1.51 versus a $1.25 estimate.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
21.4x trailing p/e — priced about right
1.4% dividend yield — cash in your pocket every quarter
13.5% return on capital — nothing to write home about
xvary composite: 56/100 — below average
What they do
CRH sells the stone, cement, concrete, asphalt, and road work that show up before your highway project gets delayed.
CRH wins because it is everywhere the heavy stuff needs to be. It runs 3,960 locations across 29 countries, and that local network matters because rock and concrete are expensive to move. Scale → more plants near the job site → lower delivery pain, so you care when operating margin reaches 19.5%.
industrials large-cap building-materials infrastructure us-exposure
How they make money
$37.4B annual revenue · their business grew +5.3% last year
Americas Materials
$16.8B
+9%
Americas Building
$7.1B
0%
International
$13.5B
+6%
The products that matter
supplies core construction materials
Aggregates, cement, asphalt and concrete
$37.4B revenue · +5.3% growth
it's the heart of the entire $37.4B business, and it still grew 5.3% last year while supporting a 10.8% net margin. this is not optional demand when roads, bridges, and job sites need material.
full business
Key numbers
74%
U.S. profit share
That is the share of 2025 net income tied to the U.S. The company looks global, but your profit stream is mostly American.
19.5%
operating margin
Operating margin → profit left after running the business → so what: CRH keeps nearly 20 cents from each sales dollar before interest and taxes.
$16.5B
long-term debt
That debt equals 17% of capital, which means leverage is present but not dominating the balance sheet.
13.5%
return on capital
Return on capital → profit earned on the money put into the business → so what: CRH is turning heavy assets into respectable returns.
Financial health
B++
strength
  • balance sheet grade B++ — above average financial health
  • risk rank 3 — safer than 50% of stocks
  • price stability 75 / 100
  • long-term debt $16.5B (17% of capital)
  • net profit margin 12.5% — keeps 12 cents of every dollar in revenue
  • return on equity 20% — $0.20 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market

You invested $10,000 in CRH 3 years ago → it's now worth $24,400.

The index would have given you $14,540.

source: institutional data · total return
What just happened
beat estimates
CRH posted a clean beat, with quarterly EPS of $1.51 versus a $1.25 estimate.
Latest-quarter revenue was $28.0B, up 153% vs. prior year, while EPS reached $3.99, up 81%. The backdrop was strongest in Americas Materials, where annual sales rose 9% to $17B.
$9.4B
revenue
$3.99
eps
36.3%
gross margin
the number that mattered
The key number was the 20.8% earnings beat, because it shows CRH is still out-earning expectations even after the stock climbed to 21.4 times trailing earnings.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the #1 risk is construction volume and infrastructure spending slowing at the same time.

med
volume rolls over
CRH sells the bones of construction. If public works, commercial projects, or residential starts weaken, the full materials chain feels it.
That pressure runs straight through the entire $37.4B revenue base because this snapshot shows no major business line outside construction materials.
med
input costs rise faster than pricing
This is heavy, energy-intensive, freight-heavy production. If fuel, transport, or raw-material costs move faster than contract repricing, margins compress.
A 10.8% net margin is healthy, but it is not so wide that cost inflation becomes somebody else's problem.
med
cyclical business, real debt load
$16.5B of long-term debt looks manageable with a B++ balance sheet. It also means you should care about cash generation more than you would in a capital-light business.
If the cycle turns down, balance-sheet flexibility matters fast — especially when 100% of the business is tied to construction demand.
a slowdown here does not hit one side business. it pressures the whole company, because the whole company is construction materials.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
watch whether margin stays above 10%
10.8% net margin is the proof that CRH is doing more than just riding volume. if that slips, the quality story weakens fast.
trend
track revenue growth against the current 5.3% pace
steady top-line growth is fine. deceleration without a valuation reset is less fine.
calendar
next earnings need to confirm the Q4 pattern
Q4 showed earnings growing faster than sales. you want to see whether that was repeatable or just a good quarter.
risk
keep an eye on construction demand indicators
if project activity softens, CRH does not have an unrelated growth engine to hide behind.
Analyst rankings
short-term outlook
average
momentum score 3 — in human-speak, analysts think CRH is acting like a normal stock right now, not flashing an unusual short-term signal.
risk profile
average
stability score 3 — this sits around the middle of the risk pack. not a bunker stock, not a wreck.
chart momentum
top 20%
technical score 2 — the chart has been stronger than most stocks, which helps explain why a cyclical name can still trade at 21.4x earnings.
source: institutional data
Institutional activity

institutions have been net buying for 2 consecutive quarters — 450 buyers vs. 284 sellers in 4q2025. total institutional holdings: 0.6B shares. net buying for 2 quarters.

source: institutional data
Price targets
3-5 year target range
$95 $181
$118 current price
$138 target midpoint · +17% from current · 3-5yr high: $190 (+60% · 14% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
CRH
xvary deep dive
crh
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it